1. Home
  2. BBNX vs PRLB Comparison

BBNX vs PRLB Comparison

Compare BBNX & PRLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBNX
  • PRLB
  • Stock Information
  • Founded
  • BBNX 2015
  • PRLB 1999
  • Country
  • BBNX United States
  • PRLB United States
  • Employees
  • BBNX N/A
  • PRLB N/A
  • Industry
  • BBNX Medical/Dental Instruments
  • PRLB Metal Fabrications
  • Sector
  • BBNX Health Care
  • PRLB Industrials
  • Exchange
  • BBNX Nasdaq
  • PRLB Nasdaq
  • Market Cap
  • BBNX 967.6M
  • PRLB 928.0M
  • IPO Year
  • BBNX 2025
  • PRLB 2012
  • Fundamental
  • Price
  • BBNX $21.86
  • PRLB $55.13
  • Analyst Decision
  • BBNX Strong Buy
  • PRLB Hold
  • Analyst Count
  • BBNX 11
  • PRLB 3
  • Target Price
  • BBNX $26.09
  • PRLB $43.50
  • AVG Volume (30 Days)
  • BBNX 540.2K
  • PRLB 184.9K
  • Earning Date
  • BBNX 10-28-2025
  • PRLB 10-31-2025
  • Dividend Yield
  • BBNX N/A
  • PRLB N/A
  • EPS Growth
  • BBNX N/A
  • PRLB N/A
  • EPS
  • BBNX N/A
  • PRLB 0.61
  • Revenue
  • BBNX $78,022,000.00
  • PRLB $508,637,000.00
  • Revenue This Year
  • BBNX $43.04
  • PRLB $6.76
  • Revenue Next Year
  • BBNX $35.60
  • PRLB $4.74
  • P/E Ratio
  • BBNX N/A
  • PRLB $89.90
  • Revenue Growth
  • BBNX 550.45
  • PRLB N/A
  • 52 Week Low
  • BBNX $8.89
  • PRLB $26.45
  • 52 Week High
  • BBNX $26.66
  • PRLB $55.90
  • Technical
  • Relative Strength Index (RSI)
  • BBNX 54.20
  • PRLB 60.68
  • Support Level
  • BBNX $19.52
  • PRLB $52.47
  • Resistance Level
  • BBNX $22.54
  • PRLB $55.90
  • Average True Range (ATR)
  • BBNX 1.36
  • PRLB 1.84
  • MACD
  • BBNX -0.07
  • PRLB 0.26
  • Stochastic Oscillator
  • BBNX 60.15
  • PRLB 89.95

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

About PRLB Proto Labs Inc. Common stock

Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. Proto Labs uses injection molding, computer numerical control machining, and 3-D printing to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.

Share on Social Networks: